Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients



Status:Completed
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:10/14/2017
Start Date:October 2007
End Date:April 2013

Use our guide to learn which trials are right for you!

Double-Blind, Randomized Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients

It has been shown that the stress that occurs during cardiac surgery leads to early decrease
of many of the body's resources such as Vitamin C (ascorbic acid) which may contribute to
complications after surgery.

This study will investigate the effects of high doses of intravenous (IV) Vitamin C on the
outcome and complications after cardiac surgery.

Patients undergoing cardiac surgery are at significant risk for multiple major complications
beyond those associated with other major operations. Most patients survive these events, but
up to 10% develop injury to organ systems including the kidneys, lungs, pancreas, brain, etc.
It has been shown that the stress that occurs during this critical period (cardiac surgery)
leads to early decrease of many of the body's resources such as Vitamin C (ascorbic acid)
which seem to contribute to these complications.

This study will investigate the effects of high doses of intravenous (IV) Vitamin C
administered before, during and after the cardiac surgery.

Inclusion Criteria:

- Adult patients 18 years or older undergoing elective or urgent (prior to hospital
discharge) cardiac surgery.

Exclusion Criteria:

- History of renal insufficiency, nephrolithiasis, G6PD (glucose-6-phosphate
dehydrogenase deficiency) or the chronic use of steroids.
We found this trial at
1
site
New Brunswick, New Jersey 08903
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials